These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26314244)

  • 21. Use of proteins to minimize the physical aging of EUDRAGIT sustained release films.
    Kucera SA; McGinity JW; Zheng W; Shah NH; Malick AW; Infeld MH
    Drug Dev Ind Pharm; 2007 Jul; 33(7):717-26. PubMed ID: 17654020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anion-induced water flux as drug release mechanism through cationic Eudragit RS 30D film coatings.
    Wagner KG; Gruetzmann R
    AAPS J; 2005 Oct; 7(3):E668-77. PubMed ID: 16353943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymers with pH-dependent solubility: possibility of use in the formulation of gastroresistant and controlled-release matrix tablets.
    Palmieri GF; Michelini S; Di Martino P; Martelli S
    Drug Dev Ind Pharm; 2000 Aug; 26(8):837-45. PubMed ID: 10900540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers.
    Maejima T; McGinity JW
    Pharm Dev Technol; 2001; 6(2):211-21. PubMed ID: 11416995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D.
    Wu C; McGinity JW
    Pharm Dev Technol; 2003; 8(1):103-10. PubMed ID: 12665203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions.
    Tang X; Tai LY; Yang XG; Chen F; Xu HM; Pan WS
    Drug Dev Ind Pharm; 2013 Jan; 39(1):67-76. PubMed ID: 22339718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores.
    Kállai N; Luhn O; Dredán J; Kovács K; Lengyel M; Antal I
    AAPS PharmSciTech; 2010 Mar; 11(1):383-91. PubMed ID: 20237965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I; Bodmeier R
    Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellulose Acetate Butyrate: Ammonio Methacrylate Copolymer Blends as a Novel Coating in Osmotic Tablets.
    Ali R; Walther M; Bodmeier R
    AAPS PharmSciTech; 2018 Jan; 19(1):148-154. PubMed ID: 28634790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
    Sauer D; McGinity JW
    Drug Dev Ind Pharm; 2009 Jun; 35(6):646-54. PubMed ID: 19337869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When drugs plasticize film coatings: Unusual formulation effects observed with metoprolol and Eudragit RS.
    Karrout Y; Siepmann F; Benzine Y; Paccou L; Guinet Y; Hedoux A; Siepmann J
    Int J Pharm; 2018 Mar; 539(1-2):39-49. PubMed ID: 29337184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
    Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
    Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA; Basit AW
    Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel use of Eudragit NE 30D/Eudragit L 30D-55 blends as functional coating materials in time-delayed drug release applications.
    El-Malah Y; Nazzal S
    Int J Pharm; 2008 Jun; 357(1-2):219-27. PubMed ID: 18353571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quaternary polymethacrylate-magnesium aluminum silicate films: molecular interactions, mechanical properties and tackiness.
    Rongthong T; Sungthongjeen S; Siepmann J; Pongjanyakul T
    Int J Pharm; 2013 Dec; 458(1):57-64. PubMed ID: 24144950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.